ADMA BIOLOGICS, INC. (ADMA) Return on Tangible Equity

ADMA BIOLOGICS, INC. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

• ADMA BIOLOGICS, INC. return tang equity for the quarter ending 2026-06-30 was 41.80%, a 21.11% decline year-over-year.
• ADMA BIOLOGICS, INC. return tang equity for the quarter ending 2026-03-31 was 42.80%, a 23.53% decline year-over-year.
• ADMA BIOLOGICS, INC. return tang equity for the quarter ending 2025-12-31 was 31.04%, a 45.82% decline year-over-year.
• ADMA BIOLOGICS, INC. return tang equity for the quarter ending 2025-09-30 was 49.03%, a 63.98% increase year-over-year.
• ADMA BIOLOGICS, INC. return tang equity for fiscal 2025 was 31.04%, a 45.82% decline from fiscal 2024.
• ADMA BIOLOGICS, INC. return tang equity for fiscal 2024 was 57.29%, a change of 78.82% from fiscal 2023.
• ADMA BIOLOGICS, INC. return tang equity for fiscal 2023 was -21.53%, a change of 23.17% from fiscal 2022.
• ADMA BIOLOGICS, INC. return tang equity for fiscal 2022 was -44.70%, a change of 8.01% from fiscal 2021.